Quick Takeaways
- Adrian Adams has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $541,013.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Adrian Adams
- Location
- Chesterbrook, PA
- Summary
- The estimated net worth of Adrian Adams is at least $541,013 dollars as of 24 Oct 2025. Adrian Adams is the Director of Akebia Therapeutics, Inc. and owns shares of Akebia Therapeutics, Inc. (AKBA) stock worth about $525.3K. Adrian Adams is the Director of TALPHERA, INC. and owns shares of TALPHERA, INC. (TLPH) stock worth about $15.7K.
- Signature
- /s/ Martha Adler, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Adrian Adams and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Akebia Therapeutics, Inc. ($525,310).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Adrian Adams
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | Director | $525,310 | 10 Jun 2025 | ||
| TLPH | TALPHERA, INC. | Director | $15,703 | 23 Oct 2025 | ||
| IMPL | IMPEL PHARMACEUTICALS INC | COB, CEO and President, Director | 14 Feb 2023 |
Insider Transactions Reported by Adrian Adams:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.